Interessante podcast e video della dr.ssa Andi Locke Mears (per chi capisce l’inglese) che riprende i risultati di un articolo peer-reviewed, lo si trova a questo link su Pubmed) che, ancora una volta, conferma l’importanza di elementi “non fisico/chimici” nella genesi e nel trattamento di malattie.

In sintesi, per chi non vuole leggere/ascoltare/vedere:

  • esperimento condotto su un gruppo di pazienti affetti da IBS (Irritable Bowel Symptoms – problemi intestinali di vario tipo)
  • I partecipanti all’esperimento vengono divisi in tre gruppi: ad un gruppo viene fatta fare pratica di Yoga della risata (ne abbiamo parlato più volte con l’amico Daniele Berti, e l’ho citato anche nel corso Dimagrigione), ad un secondo gruppo vengono dati farmaci contro l’ipertensione (i problemi intestinali sono spesso legati all’ipertensione) e al terzo gruppo (il classico gruppo di controllo) non viene fatto nulla;
  • A fronte di parametri quantitativi ed oggettivi rilevati prima e dopo l’esperimento,
  • i risultati confermano la efficacia dello Yoga della risata, mettendolo addirittura davanti alle cure farmacologiche.

La dr.ssa Andi spiega poi come mai, alla luce della NMG, questo sia molto chiaro: parla del conflitto del boccone indigesto, e di come il nostro fisico, così come non distingue tra shock fisici e percepiti, generadno “soluzioni” come l’aumento di funzione e/o di massa di certi organi preposti, allo stesso modo non percepisce la differenza fra una soluzione “reale” ed una “immaginata” come quella che può essere indotta da una risata “artificiale“.

Come dice Marisa Peer, imbrogliamo il nostro corpo (lei dice il nostro subconscio) per guarire. O, più semplicemente, disinneschiamo alcuni processi incastrati che ci impediscono di vivere in perfetta armonia e salute.

Un’altra conferma della grandezza delle scoperte del dr.Hamer.

https://www.youtube.com/watch?v=oxk90_cQLik&feature=youtu.be&ab_channel=AndiLockeMears

.

 

______________________________________

Articolo originale Andi Locke Mears:

 

Laughter Yoga & IBS – A GNM View

2/3/2020

0 Comments

Picture

You can listen to this as a podcast, or watch it as a video.

Today, we’re looking at a study that explored whether or not laughter helps folks with IBS and we’ll look at this from it GNM perspective.

IBS is Common
Irritable bowel syndrome is the most common chronic gastrointestinal disorder.

According to the Mayo clinic, symptoms include cramping, abdominal pain, bloating, gas and diarrhea or constipation or both.

The main objective of the study was to see what was more effective for physical, GI tract symptoms and to reduce the anxiety that is often associated with IBS:

  • Laughter yoga or
  • Medication

This was a randomized controlled clinical trial involving 60 people.

Each of them was assigned randomly to either the laughter yoga group, the antianxiety medication group, or the control group, which experienced nothing.

The severity levels of their anxiety and the GI tract symptoms before and after laughter yoga and the meds were determined and compared among the three groups.

And the results were that the severity of the IBS symptoms were more greatly reduced in the laughter yoga group than in the anti-anxiety medication group and the control group.

Laughter Won!
They concluded that laughter yoga is more effective than antianxiety meds in reducing the GI tract symptoms of patients with IBS.

So the question is: Why would laughter be more effective than meds at reducing the severity of the physical symptoms?

The answer from a GNN perspective is because laughter addresses what we’ll call the root cause of IBS. In other words, it addresses the conflict shock that was experienced.

Let’s go deeper!

Why Laughter Won
The conflict that initiates what is known as “IBS” is an indigestible morsel conflict. It’s also known as an indigestible chunk conflict.

What the heck is that, right?!

In the animal kingdom, it’s some sort of distress about food such as not catching their prey, not having enough to eat, etc.

For humans it’s usually figurative. It’s an idea, an event, some news, a situation, something that’s difficult to accept, something too difficult to digest in your life.

In the case of the colon, which is where “IBS” takes place, it’s a rather ugly conflict such as a horrible divorce, fighting with siblings about an inheritance, betrayed by someone that you love.  All are distressing events that are difficult to accept in your life.

Let’s say Jane & Jim are having a nasty divorce. Lots of disputes about the house, the kids, and it’s been dragging on for a year.

Jane experienced a conflict shock when she learned Jim was contesting the divorce.  She is now getting letters from Jim’s attorney and it’s a difficult experience.

Because we know GNM, we know that Dr. Hamer discovered there is cell growth in the conflict active phase for this particular program.

Her body knew exactly what to do to help her get through this easier so her brain directed her colon to grow extra cells to increase the amount of digestive juices so she could digest that morsel.

Logical, right?

It makes no difference if it’s a physical morsel (food) or a figurative morsel (an event).  From a biological standpoint, they are both threats to which our hardwiring responds.

Once the conflict is resolved, the divorce is sorted out and resolutions reached, Jane’s  microbes are turned on and they will remove these extra cells because they are no longer needed.

This healing phase may be uncomfortable with diarrhea, blood in stools, abdominal cramping, and night sweats. This is what is commonly called, “being sick,” or “having a disease.”

If Jane isn’t able to resolve this quickly, she may have conflict relapses which will start the program over again.

Jane realizes that going to the mailbox is incredibly stressful because there may be another letter from her husband’s attorney.  The first one she received was a shock and now the mailbox is seen as a danger from your psyche.

Heading to the mailbox is now anxiety-ridden and the program is activated again.  If this occurs enough, Jane’s body will be stuck in a cycle of cell growth, then incomplete cell breakdown, then cell growth, then incomplete cell breakdown.  This is when her doctor gave her the label of “IBS.”

What does laughter do? 
We already know that the medications didn’t reduce the anxiety enough to reduce the physical symptoms. But the Laughter yoga, made an impact. Why?

I checked out laughteryoga.org which hosts the Laughter Yoga University.

I’ve experienced Laughter Yoga before, and it’s really a lot of fun.

What’s interesting is your body doesn’t see the difference between real laughter and fake laughter……just like it can’t tell the difference between a physical or figurative morsel conflict.

Real or fake – your body knows to respond. 
The benefits of laughter include:

  • it helps to change your mood within minutes by releasing endorphins, those brain chemicals that make you feel good, so you’re in a better mood.
  • It brings more oxygen to your body and your brain so you feel more energized and yet more relaxed. It’s a lot like aerobic exercise.
  • It reduces stress and improves relationships because people like to be around others who laugh.
  • It helps to create a positive mental state to deal with negative situations and negative people.
  • It gives hope and optimism to cope with difficult times.

Bingo.

So how would laughter yoga help Jane?  It would give her hope and optimism so she could better cope with the stresses due to the divorce.

Her conflict shock and conflict active phase would have been less intense.  Thus, her healing phase would also not have been as intense.  Perhaps she wouldn’t have even received the label of “IBS.”

If Jane did laughter yoga right before checking the mailbox, her feel-good biochemicals are increased which means the shock of seeing another letter from the attorney may not be seen as such a threat which downgrades the entire program.

Laughter, then, plays a part at minimizing or interrupting the  cycle of cell growth and cell breakdown.

Please pass this on to anyone you know who’s been diagnosed with IBS and maybe it can help them and share this on your social media.

I’d love to hear from you; let me know what else you’d like me to talk about.
​
Hope to see you next time. Until later.

Links to Resources:
IBS info:
https://www.mayoclinic.org/diseases-conditions/irritable-bowel-syndrome/symptoms-causes/syc-20360016
Pubmed Study on Laughter Yoga and IBS:
https://pubmed.ncbi.nlm.nih.gov/31824624-comparison-of-laughter-yoga-and-anti-anxiety-medication-on-anxiety-and-gastrointestinal-symptoms-of-patients-with-irritable-bowel-syndrome/?dopt=Abstract&utm_campaign=Chris%20Kresser&utm_source=hs_email&utm_medium=email&utm_content=80760526&_hsenc=p2ANqtz-8E5ovpYWVoW3EKu9jG9X-LZjmOsMfH3eKWSAEIfLQWThAqlraIXD6tHhJIuNSWtxxI90NpK7QBkz6UxxVObV6TF_gJog&_hsmi=80760526
Laughter yoga:
https://laughteryoga.org/laughter-yoga/about-laughter-yoga/

 

Articolo originale su PubMed:

. 2019 Oct;11(4):211-217.

doi: 10.15171/mejdd.2019.151. Epub 2019 Nov 5.

Comparison of Laughter Yoga and Anti-Anxiety Medication on Anxiety and Gastrointestinal Symptoms of Patients with Irritable Bowel Syndrome

Tahmine Tavakoli 1, Navid Davoodi 1, Toktam Sadat Jafar Tabatabaee 2, Zeinab Rostami 3, Homa Mollaei 4, Fatemeh Salmani 5, Sara Ayati 1, Sanaz Tabrizi 1
Affiliations 

Free PMC article

Abstract

BACKGROUND Irritable bowel syndrome (IBS) is the most common chronic gastrointestinal (GI) disorder. Patients with IBS usually suffer from anxiety and depression. A combination of psychological approaches and pharmacological treatments can be a significantly effective treatment for IBS. The main objective of the present study was to provide a therapeutic plan based on laughter yoga and anti-anxiety medication, employed for the very first time, and to determine the effectiveness of these treatments on the anxiety and GI symptoms of patients with IBS. METHODS In this randomized, controlled, clinical trial, the participants were 60 patients selected from those who referred to the GI clinic of Vali-asr Hospital (Birjand, Iran) during the study period (April 2017 to March 2017) and were diagnosed as having IBS based on ROME III criteria. The participants were randomly assigned to either the laughter yoga group, the anti-anxiety medication group, or the symptomatic treatment (control) group. Severity levels of anxiety and GI symptoms before and after intervention were determined and compared among these three groups according to approved protocols. RESULTS The severity of IBS symptoms after the interventions was more greatly reduced in the laughter yoga group than in the anti-anxiety medication and control groups (p = 0.006). The severity of anxiety after interventions decreased in all three groups, especially in the yoga treatment group, but the difference was not statistically significant (p = 0.1). CONCLUSION Laughter yoga is more effective than anti-anxiety medication in reducing the GI symptoms of patients with IBS. Therefore, applying laughter yoga along with common pharmacological therapies for patients with IBS might be strongly advised.

Keywords: Anxiety; Chronic Gastrointestinal Disorder; Gastrointestinal Symptoms; Irritable Bowel Syndrome; Laughter Yoga.

Conflict of interest statement

CONFLICT OF INTEREST The authors declare no conflict of interest related to this work.

Figures

Fig. 1

Fig. 2

Similar articles

See all similar articles

References

    1. Iftikhar B, Naveed H, Khalil K, ur Rehman H, Khushbaght Khushbaght. Prevalence of Irritable Bowel Syndrome and it’s Risk Factors Among Medical Students of Peshawar, Pakistan. Pakistan J Med Res. 2018;57:24–8.
    1. Klem F, Wadhwa A, Prokop LJ, Sundt WJ, Farrugia G, Camilleri M. et al. Prevalence, risk factors, and outcomes of irritable bowel syndrome after infectious enteritis: a systematic review and meta-analysis. Gastroenterology. 2017;152:1042–54. doi: 10.1053/j.gastro.2016.12.039. – DOI – PMC – PubMed
    1. Williams M. Irritable bowel syndrome: the latest thinking. J Community Nursing. 2018;32:28–33.
    1. Markland AD, Jelovsek JE, Rahn DD, Wang L, Merrin L, Tuteja A. et al. Irritable bowel syndrome and quality of life in women with fecal incontinence. Female Pelvic Med Reconstr Surg. 2017;23:179–83. doi: 10.1097/SPV.0000000000000358. – DOI – PMC – PubMed
    1. Sunderland R. Irritable bowel syndrome in adults: symptoms, treatment and management. Nurs Stand. 2017;31:52–63. doi: 10.7748/ns.2017.e10654. – DOI – PubMed
    1. McCullough R, McCullough J. Deciphering the pathophysiology of irritable bowel syndrome and functional gastrointestinal disorders-an alternative model for pathogenesis: cytokine controlled transepithelial multi-feedback loop. Transl Gastroenterol Hepatol. 2017;2:18. doi: 10.21037/tgh.2017.03.02. – DOI – PMC – PubMed
    1. Drossman DA, Hasler WL. Rome IV-functional GI disorders: disorders of gut-brain interaction. Gastroenterology. 2016;150:1257–61. doi: 10.1053/j.gastro.2016.03.035. – DOI – PubMed
    1. Kawoos Y, Wani ZA, Kadla SA, Shah IA, Hussain A, Dar MM. et al. Psychiatric Co-morbidity in Patients With Irritable Bowel Syndrome at a Tertiary Care Center in Northern India. J Neurogastroenterol Motil. 2017;23:555–60. doi: 10.5056/jnm16166. – DOI – PMC – PubMed
    1. Lackner JM, Ma CX, Keefer L, Brenner DM, Gudleski GD, Satchidanand N. et al. Type, rather than number, of mental and physical comorbidities increases the severity of symptoms in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2013;11:1147–57. doi: 10.1016/j.cgh.2013.03.011. – DOI – PMC – PubMed
    1. Yazdani M, Esmaeilzadeh M, Pahlavanzadeh S, Khaledi F. The effect of laughter yoga on general health among nursing students. Iran J Nurs Midwifery Res. 2014;19:36–40. – PMC – PubMed
    1. DeCaro DS, Constantine Brown JL. Laughter Yoga, Adults Living With Parkinson׳ s Disease, and Caregivers: A Pilot Study. Explore (NY) 2016;12:196–9. doi: 10.1016/j.explore.2016.02.005. – DOI – PubMed
    1. Shahabizade F, Hassanzadeh-Taheri M, Fatemi S, Moodi H, Hosseini M, Akbari A. et al. Evaluating the impact of laughter therapy on hope, self-efficacy, and pain control in patients with chronic low back pain. Pharmacophore. 2017;8:e–1173662.
    1. Umamah F, Mufarrihah N. Pengaruh terapi tertawa terhadap tingkat kecemasan pada lanjut usia di uptd griya werdha surabaya. J Health Sci. 2018;11 doi: 10.33086/jhs.v11i1.116. – DOI
    1. Briggs JP, Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J. Complementary, Alternative, and Integrative Health Practices. Harrison’s principles of internal medicine. 2015
    1. Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997;11:395–402. doi: 10.1046/j.1365-2036.1997.142318000.x. – DOI – PubMed
    1. Beck AT, Steer RA, Ball R, Ranieri W. Comparison of Beck Depression Inventories-IA and-II in psychiatric outpatients. J Pers Assess C. 1996;67:588–97. – PubMed
    1. Dabson K, Mohammad KP. Psychometric characteristics of Beck depression inventory–II in patients with major depressive disorder. J Pers Assess. 1996;67:588–97. doi: 10.1207/s15327752jpa6703_13. – DOI – PubMed
    1. Mahdipour MZ, Davoudi A. Comparison of the Effectiveness of Psychological-Pharmaceutical Combined Therapy with Drug Therapy on Mental Health, Improving Quality of Life and Symptoms Reduction in Patients with Irritable Bowel Syndrome in Ahwaz. 2012;3
    1. Weisse AB. editor Humor in medicine: Can laughter help in healing? Proc (Bayl Univ Med Cent) 2017;30:378–81. doi: 10.1080/08998280.2017.11929656. – DOI – PMC – PubMed
    1. Greenberg M AH, Galiczynski E. A contemporary review of IBS. Phys Assist. 2002;26:26–33.
    1. Solati Dehkordy K, Adibi P, Ghamarani A. The effects of cognitive–behavior therapy and drug therapy on quality of life and symptoms of patients with irritable bowel syndrome. J Kerman Uni Med Sci. 2012;19
    1. Hussein poor A EN, Chitaz A. The effect of eight weeks of laughing yoga exercises on motor function, balance and flexibility of patients with Parkinson’s disease. Res Rehabilit Sci. 2013;9:39–47.
    1. Creed F, Fernandes L, Guthrie E, Palmer S, Ratcliffe J, Read N. et al. The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome. Gastroenterology. 2003;124:303–17. doi: 10.1053/gast.2003.50055. – DOI – PubMed
    1. Drossman D, Morris CB, Hu Y, Toner BB, Diamant N, Whitehead WE. et al. Characterization of health related quality of life (HRQOL) for patients with functional bowel disorder (FBD) and its response to treatment. Am J Gastroenterol. 2007;102:1442–53. doi: 10.1111/j.1572-0241.2007.01283.x. – DOI – PubMed
    1. Lackner JM, Gudleski GD, Keefer L, Krasner SS, Powell C, Katz LA. Rapid response to cognitive behavior therapy predicts treatment outcome in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2010;8:426–32. doi: 10.1016/j.cgh.2010.02.007. – DOI – PMC – PubMed
    1. Camilleri M, Northcutt AR, Kong S, Dukes GE, McSorley D, Mangel AW. Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial. Lancet. 2000;355:1035–40. doi: 10.1016/S0140-6736(00)02033-X. – DOI – PubMed
    1. Moss-Morris R, McAlpine L, Didsbury L, Spence M. A randomized controlled trial of a cognitive behavioural therapy-based self-management intervention for irritable bowel syndrome in primary care. Psychol Med. 2010;40:85–94. doi: 10.1017/S0033291709990195. – DOI – PubMed
    1. Tack J, Broekaert D, Fischler B, Van Oudenhove L, Gevers AM, Janssens J. A controlled crossover study of the selective serotonin reuptake inhibitor citalopram in irritable bowel syndrome. Gut. 2006;55:1095–103. doi: 10.1136/gut.2005.077503. – DOI – PMC – PubMed
    1. Vahedi H, Merat S, Momtahen S, Kazzazi A, Ghaffari N, Olfati G. et al. Clinical trial: the effect of amitriptyline in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther. 2008;27:678–84. doi: 10.1111/j.1365-2036.2008.03633.x. – DOI – PubMed
    1. Ladabaum U, Sharabidze A, Levin T, Zhao W, Chung E, Bacchetti P. et al. Citalopram is not-effective therapy for non-depressed patiants with irritabl bowel syndrome. Clin Gastroenterol Hepatol. 2010;81:42. – PMC – PubMed
    1. Talley NJ, Kellow JE, Boyce P, Tennant C, Huskic S, Jones M. Antidepressant therapy (imipramine and citalopram) for irritable bowel syndrome: a double-blind, randomized, placebo-controlled trial. Dig Dis Sci. 2008;53:108–15. doi: 10.1007/s10620-007-9830-4. – DOI – PubMed